Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial
Moro-Sibilot, D., Cozic, N., Pérol, M., Mazières, J., Otto, J., Souquet, P.J., Bahleda, R., Wislez, M., Zalcman, G., Guibert, S.D., Barlési, F., Mennecier, B., Monnet, I., Sabatier, R., Bota, S., Dubos, C., Verriele, V., Haddad, V., Ferretti, G., Cortot, A., De Fraipont, F., Jimenez, M., Hoog-Labouret, N., Vassal, G.
Published in Annals of oncology (01.12.2019)
Published in Annals of oncology (01.12.2019)
Get full text
Journal Article
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer
Rosell, R., Robinet, G., Szczesna, A., Ramlau, R., Constenla, M., Mennecier, B. C., Pfeifer, W., O'Byrne, K. J., Welte, T., Kolb, R., Pirker, R., Chemaissani, A., Perol, M., Ranson, M. R., Ellis, P. A., Pilz, K., Reck, M.
Published in Annals of oncology (01.02.2008)
Published in Annals of oncology (01.02.2008)
Get full text
Journal Article
From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue française (GOLF)
Couraud, S., Cortot, A.B., Greillier, L., Gounant, V., Mennecier, B., Girard, N., Besse, B., Brouchet, L., Castelnau, O., Frappé, P., Ferretti, G.R., Guittet, L., Khalil, A., Lefebure, P., Laurent, F., Liebart, S., Molinier, O., Quoix, E., Revel, M.-P., Stach, B., Souquet, P.-J., Thomas, P., Trédaniel, J., Lemarié, E., Zalcman, G., Barlési, F., Milleron, B.
Published in Annals of oncology (01.03.2013)
Published in Annals of oncology (01.03.2013)
Get full text
Journal Article
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial
Moro-Sibilot, D, Cozic, N, Pérol, M, Mazières, J, Otto, J, Souquet, P J, Bahleda, R, Wislez, M, Zalcman, G, Guibert, S D, Barlési, F, Mennecier, B, Monnet, I, Sabatier, R, Bota, S, Dubos, C, Verriele, V, Haddad, V, Ferretti, G, Cortot, A, De Fraipont, F, Jimenez, M, Hoog-Labouret, N, Vassal, G
Published in Annals of oncology (01.12.2019)
Published in Annals of oncology (01.12.2019)
Get full text
Journal Article
Efficacy of immune checkpoint inhibitors in lung sarcomatoid carcinoma: Data from a French multicentric cohort
Domblides, C., Monnet, I., Mazieres, J., Barlesi, F., Gounant, V., Baldacci, S., Mennecier, B., Toffart, A.C., Audigier Valette, C., Doucet, L., Giroux-Leprieur, E., Guisier, F., Molinier, O., Perol, M., Pichon, E., Robinet, G., Templement Grangerat, D., Ruppert, A.-M., Wislez, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer
Mignard, X, Antoine, M, Moro-Sibilot, D, Dayen, C, Mennecier, B, Gervais, R, Amour, E, Milleron, B, Morin, F, Zalcman, G, Wislez, M
Published in Revue des maladies respiratoires (01.11.2018)
Published in Revue des maladies respiratoires (01.11.2018)
Get more information
Journal Article
3062 Ceritinib following crizotinib in ALK-positive (+) advanced NSCLC patients (pts): Results from the French Temporary Authorization for Use (ATU) experience
Cadranel, J, Cortot, A, Lena, H, Mennecier, B, Do, P, Dansin, E, Mazieres, J, Chouaid, C, Perol, M, Barlesi, F
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up
Ruppert, A-M, Beau-Faller, M, Neuville, A, Guerin, E, Voegeli, A-C, Mennecier, B, Legrain, M, Molard, A, Jeung, M-Y, Gaub, M-P, Oudet, P, Quoix, E
Published in The European respiratory journal (01.02.2009)
Published in The European respiratory journal (01.02.2009)
Get full text
Journal Article
Phase II Study of Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer
Ramalingam, S.S, Mazières, J, Planchard, D, Stinchcombe, T.E, Dy, G.K, Antonia, S.J, Horn, L, Lena, H, Minenza, E, Mennecier, B, Otterson, G.A, Campos, L.T, Gandara, D.R, Levy, B.P, Nair, S.G, Zalcman, G, Wolf, J, Baudelet, C, Lestini, B.J, Rizvi, N.A
Published in International journal of radiation oncology, biology, physics (01.12.2014)
Published in International journal of radiation oncology, biology, physics (01.12.2014)
Get full text
Journal Article
Small cell lung cancer and anti-Hu syndrome
Prim, N, Mennecier, B, Behr, C, Fraisse, P, Echaniz-Laguna, A, Tranchant, C, Quoix, E
Published in Revue des maladies respiratoires (01.03.2010)
Published in Revue des maladies respiratoires (01.03.2010)
Get more information
Journal Article
Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française
Girard, N, Gounant, V, Mennecier, B, Greillier, L, Cortot, A B, Couraud, S, Besse, B, Brouchet, L, Castelnau, O, Ferretti, G R, Frappé, P, Khalil, A, Lefebure, P, Laurent, F, Liebart, S, Margery, J, Molinier, O, Quoix, E, Revel, M-P, Stach, B, Souquet, P-J, Thomas, P, Trédaniel, J, Lemarié, E, Zalcman, G, Barlési, F, Milleron, B
Published in Revue des maladies respiratoires (01.01.2014)
Published in Revue des maladies respiratoires (01.01.2014)
Get more information
Journal Article
P2.11B.05 Effect of Dysbiosis-Inducing Drugs on the Response to Immune Checkpoint Inhibitors in Patients with NSCLC
Lopes, S., Bertrand, B., Lucile, P., Creusot, Q., Mennecier, B., Pamart, G., Matau, C., Pancreach, E., Beau-Faller, M., Dory, A., Mascaux, C.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article
CN15 Real-life clinical and organizational evaluation of telemonitoring and assisted telemonitoring in more than 1500 cancer patients
Martin, S., Fritsch, A., Jouannaud, C., Martin-Babau, J., Mennecier, B., Slimano, F., Bordeau, A., Guéroult-Accolas, L., Delcour, B., Raymond, E., Renet, S., Sonntag, C., Morel, A., Barthelemy, P.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1369P BrigAlec study: Focus on alectinib efficacy after brigatinib exposure in BrigALK2 study (GFPC 02-2019)
Descourt, R., Guisier, F., Pérol, M., Cadranel, J., Duruisseaux, M., Doubre, H., Culine, S., Lamour, C., Moro-Sibilot, D., Mennecier, B., Martin, N., Bylicki, O., Chouaid, C., Greillier, L.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Prolonged response with paclitaxel after immunotherapy by pembrolizumab in lung cancer
Zapata, E, Mennecier, B, Leduc, C, Chatron, E, Quoix, E
Published in Revue de pneumologie clinique (01.10.2016)
Published in Revue de pneumologie clinique (01.10.2016)
Get full text
Journal Article
1200P BrigALK2 study: A multicentric real-world study evaluating brigatinib in ALK positive advanced pre-treated non-small cell lung cancers: Long-term follow-up with focus on lorlatinib efficacy after brigatinib
Descourt, R., Pérol, M., Rousseau-Bussac, G., Planchard, D., Mennecier, B., Wislez, M., Cadranel, J., Cortot, A.B., Guisier, F., Galland, L., Do, P., Schott, R., Dansin, E., Arrondeau, J., Auliac, J.B., Chouaid, C.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article